Search Orphan Drug Designations and Approvals
-
Generic Name: | Glyceol |
---|---|
Date Designated: | 02/22/1990 |
Orphan Designation: | To decrease intracranial hypertension and/or alleviate cerebral edema in patients who may benefit from osmotherapy. |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Chugai Pharmaceutical Co., Ltd.
The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-